Inventor

STAMFORD ANDREW

US62 patents

⚠️ This page may combine multiple inventors who share the name “STAMFORD ANDREW”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

STAMFORD ANDREW

SCHERING CORP

Heterocyclic aspartyl protease inhibitors

Heterocyclic aspartyl protease inhibitors

2-Alkynyl-and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists

Cyclic amine bace-1 inhibitors having a heterocyclic substituent

Aspartyl protease inhibitors

Heterocyclic aspartyl protease inhibitors

Cyclic amine BACE-1 inhibitors having a benzamide substituent

Heteroaryl urea neuropeptide Y Y5 receptor antagonists

Heterocyclic aspartyl protease inhibitors

Heteroaryl urea neuropeptide Y Y5 receptor antagonists

Macrocyclic heterocyclic aspartyl protease inhibitors

Bicyclic guanidine derivatives as asparyl protease inhibitors, compositions, and uses thereof

Substituted spiro iminopyrimidinones as aspartyl protease inhibitors, compositions, and methods of treatment

Adenosine Aa2 receptor antagonists

Pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists

Cyclic amine BACE-1 inhibitors having a heterocyclic substituent

2-heteroaryl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists

2-alkynyl- and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists

Heteroaryl urea neuropeptide Y Y5 receptor antagonists

Neuropeptide receptor modulators

Xanthine phosphodiesterase V inhibitors

Metabolite of xanthine Phosphodiesterase 5 inhibitor and derivatives thereof useful for treatment of erectile dysfunction

MERCK SHARP & DOHME

Aminopyrazine compounds with A2A antagonist properties

Heterobicyclo-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with A2A anatagonist properties

Substituted quinolizine derivatives useful as HIV integrase inhibitors

Piperazine-substituted [1,2,4]triazolo[1,5-C]quinazolin-5-amine compounds with A2A antagonist properties

Compounds inhibiting leucine-rich repeat kinase enzyme activity

Compounds inhibiting leucine-rich repeat kinase enzyme activity

Spiro-imidazolone derivatives as glucagon receptor antagonists

Compounds inhibiting leucine-rich repeat kinase enzyme activity

Mineralocorticoid receptor antagonists

Compounds inhibiting leucine-rich repeat kinase enzyme activity

2,2-difluorodioxolo A2A receptor antagonists

GIRIJAVALLABHAN VINAY

2′-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases

2′-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases

2′-cyano substituted nucleoside derivatives and methods of use thereof useful for the treatment of viral diseases

ZHU ZHAONING

Heterocyclic aspartyl protease inhibitors

Thiophenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as BACE-1 inhibitors, compositions, and their use

Heterocyclic aspartyl protease inhibitors

CUMMING JARED N

Cyclic amine BACE-1 inhibitors having a benzamide substituent

Cyclic amine BACE-1 inhibitors having a benzamide substituent

WU YUSHENG

Aspartyl protease inhibitors

Aspartyl protease inhibitors

ISERLOH ULRICH

Macrocyclic heterocyclic aspartyl protease inhibitors

PHARMACOPEIA DRUG DISCOVERY

Cyclic amide BACE-1 inhibitors having a benzamide substituent

GREENLEE WILLIAM J

Glucagon receptor antagonists, compositions, and methods for their use

UNIV CORNELL

Pyridinone- and pyridazinone-based compounds and uses thereof

STAMFORD ANDREW

Substituted isoindolines as aspartyl protease inhibitors

HARRIS JOEL M

Bridged bicyclic piperidine derivatives and methods of use thereof

NEELAMKAVIL SANTHOSH FRANCIS

Pyrimidine ether derivatives and methods of use thereof